VectivBio
VECT
$16.85
Share price
0.00%
Change (1 day)
206.92%
Change (1 year)
Categories
VectivBio (VECT) - Cash on Hand
Cash on Hand as of December 2022 : $0.22 B
According to VectivBio's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
VectivBio - Cash on Hand chart (from 2020 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.22 B | 115.57% |
| 2021-12-31 | $0.10 B | 155.65% |
| 2020-12-31 | $40.17 M | 102.65% |
| 2019-12-31 | $19.82 M | 827.27% |
| 2018-12-31 | $2.13 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -97.61% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -43.36% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 156.76% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 311.27% | Jersey |